Literature DB >> 21380578

Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection.

Zhiliang Wu1, Thidarut Boonmars, Sirintip Boonjaraspinyo, Isao Nagano, Somchai Pinlaor, Anucha Puapairoj, Puangrat Yongvanit, Yuzo Takahashi.   

Abstract

Opisthorchiasis-associated cholangiocarcinoma (CCA) is one of main public health problems in Opisthorchis viverrini endemic areas. Although the definite relationship between prevalence of CCA and the parasite infection has been demonstrated, the molecular mechanism of tumorigenesis is still unknown. In the present study, by using animal model of opisthorchiasis-associated CCA, a kinetic analysis of cDNA microarray was performed to screen the candidate genes that involve in the development of opisthorchiasis-associated CCA. Microarray analysis revealed that the expressions of 131 genes were up-regulated during the development of CCA, including the genes relative to cell proliferation, differentiation and transformation, cell growth and cycle regulation, apoptosis, DNA repair, and cytoskeletal structure. The expressions of 145 genes were down-regulated, including the genes relative to metabolic enzymes, tumor suppressor, apoptosis, and oxidative response and oxidation reduction. The present study listed up the candidate genes involving tumorigenesis, provided molecular information on the development of opisthorchiasis-associated CCA and the potential biomarkers for diagnosis and therapy, and suggested that the increased expression of cell differentiation, proliferation, transformation-related genes, and decreased expression of metabolic enzymes may play important roles in the tumorigenesis of CCA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21380578     DOI: 10.1007/s00436-011-2298-3

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  71 in total

1.  Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry.

Authors:  Irene van den Broek; Rolf W Sparidans; Jan H M Schellens; Jos H Beijnen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-01-18       Impact factor: 3.205

2.  S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.

Authors:  Xiao-Hong Wang; Lian-Hai Zhang; Xi-Yao Zhong; Xiao-Fang Xing; Yi-Qiang Liu; Zhao-Jian Niu; Yong Peng; Hong Du; Gui-Guo Zhang; Ying Hu; Ni Liu; Yu-Bing Zhu; Shao-Hua Ge; Wei Zhao; Ai-Ping Lu; Ji-You Li; Jia-Fu Ji
Journal:  Am J Pathol       Date:  2010-06-25       Impact factor: 4.307

Review 3.  Metals, toxicity and oxidative stress.

Authors:  M Valko; H Morris; M T D Cronin
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 4.  Cytokeratin markers come of age.

Authors:  Stig Linder
Journal:  Tumour Biol       Date:  2007-08-23

5.  Serine proteases HTRA1 and HTRA3 are down-regulated with increasing grades of human endometrial cancer.

Authors:  Marissa A Bowden; Lisa A Di Nezza-Cossens; Tom Jobling; Lois A Salamonsen; Guiying Nie
Journal:  Gynecol Oncol       Date:  2006-05-02       Impact factor: 5.482

6.  Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors.

Authors:  Monika Schindl; Sebastian F Schoppmann; Thomas Ströbel; Harald Heinzl; Christina Leisser; Reinhard Horvat; Peter Birner
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

7.  Apoptosis-related gene expressions in hamsters re-infected with Opisthorchis viverrini and re-treated with praziquantel.

Authors:  T Boonmars; T Srisawangwong; P Srirach; B Kaewsamut; S Pinlaor; P Sithithaworn
Journal:  Parasitol Res       Date:  2007-09-13       Impact factor: 2.289

8.  Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment.

Authors:  Masahisa Jinushi; Yukoh Nakazaki; Daniel R Carrasco; Dobrin Draganov; Nicholas Souders; Matthew Johnson; Martin C Mihm; Glenn Dranoff
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

9.  PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcoma.

Authors:  M S Lagonigro; E Tamborini; T Negri; S Staurengo; G P Dagrada; F Miselli; E Gabanti; A Greco; P G Casali; A Carbone; M A Pierotti; S Pilotti
Journal:  J Pathol       Date:  2006-04       Impact factor: 7.996

10.  Liquid chromatography/tandem mass spectrometric method for the quantification of eight proteolytic fragments of ITIH4 with biomarker potential in human plasma and serum.

Authors:  Irene van den Broek; Rolf W Sparidans; Jan H M Schellens; Jos H Beijnen
Journal:  Rapid Commun Mass Spectrom       Date:  2008-09       Impact factor: 2.419

View more
  10 in total

1.  Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen.

Authors:  Puangrat Yongvanit; Raynoo Thanan; Somchai Pinlaor; Paiboon Sithithaworn; Watcharin Loilome; Nisana Namwat; Anchalee Techasen; Somkid Dechakhamphu
Journal:  Parasitol Res       Date:  2011-12-09       Impact factor: 2.289

2.  Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma.

Authors:  Zhiliang Wu; Thidarut Boonmars; Isao Nagano; Watcharin Loilome; Puangrat Yongvanit; Narong Khuntikeo; Phuangphaka Sadee Nielsen; Chawalit Paorojkul; Yuzo Takahashi; Yoichi Maekawa
Journal:  Tumour Biol       Date:  2014-03

3.  Tumor-related gene changes in immunosuppressive Syrian hamster cholangiocarcinoma.

Authors:  Amornrat Juasook; Ratchadawan Aukkanimart; Thidarut Boonmars; Pakkayanee Sudsarn; Nadchanan Wonkchalee; Porntip Laummaunwai; Pranee Sriraj
Journal:  Pathol Oncol Res       Date:  2013-05-06       Impact factor: 3.201

4.  Immunodiagnosis of opisthorchiasis using parasite cathepsin F.

Authors:  Salma Teimoori; Yuji Arimatsu; Thewarach Laha; Sasithorn Kaewkes; Piya Sereerak; Sirikachorn Tangkawattana; Paul J Brindley; Banchob Sripa
Journal:  Parasitol Res       Date:  2015-09-07       Impact factor: 2.289

5.  Alteration of galectin-1 during tumorigenesis of Opisthorchis viverrini infection-induced cholangiocarcinoma and its correlation with clinicopathology.

Authors:  Zhiliang Wu; Thidarut Boonmars; Isao Nagano; Sirintip Boonjaraspinyo; Somchai Pinlaor; Chawalit Pairojkul; Yaovalux Chamgramol; Yuzo Takahashi
Journal:  Tumour Biol       Date:  2012-02-29

6.  Involvement of PSMD10, CDK4, and Tumor Suppressors in Development of Intrahepatic Cholangiocarcinoma of Syrian Golden Hamsters Induced by Clonorchis sinensis and N-Nitrosodimethylamine.

Authors:  Md Hafiz Uddin; Min-Ho Choi; Woo Ho Kim; Ja-June Jang; Sung-Tae Hong
Journal:  PLoS Negl Trop Dis       Date:  2015-08-27

Review 7.  An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma.

Authors:  Pattaya Seeree; Phorutai Pearngam; Supeecha Kumkate; Tavan Janvilisri
Journal:  Int J Genomics       Date:  2015-09-02       Impact factor: 2.326

8.  Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma.

Authors:  Watcharin Loilome; Sasithorn Kadsanit; Kanha Muisook; Puangrat Yongvanit; Nisana Namwat; Anchalee Techasen; Anucha Puapairoj; Narong Khuntikeo; Pichai Phonjit
Journal:  Oncol Lett       Date:  2016-12-08       Impact factor: 2.967

9.  Specific protein carbonylation in human breast cancer tissue compared to adjacent healthy epithelial tissue.

Authors:  Baikuntha Aryal; V Ashutosh Rao
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

10.  Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles.

Authors:  Nitish Kumar Mishra; Meng Niu; Siddesh Southekal; Prachi Bajpai; Amr Elkholy; Upender Manne; Chittibabu Guda
Journal:  Front Genet       Date:  2020-10-20       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.